{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:11Z","timestamp":1787010071020,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>For stage T1b-2N0-1 esophageal cancer, the impact of neoadjuvant therapy plus surgery (NS), surgery alone (SA), and surgery plus adjuvant therapy (ST) on cancer-specific survival (CSS) and overall survival (OS) is uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Stage T1b-2N0-1 esophageal cancer patients from the SEER database and two Chinese cancer centers were included in this study. The Kaplan\u2013Meier method was used to plot survival curves, which were compared using the log-rank test. Propensity score matching was used to equalize differences between the groups. Cox proportional hazards regression models were used to analyze prognostic factors. A nomogram for OS was developed after screening the variables using the Cox proportional hazards regression model and the least absolute shrinkage and selection operator. The performance of the nomogram was assessed by the Harrell concordance index (C-index), the area under the curve (AUC) of the receiver operating characteristic curve, calibration plots, and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After propensity score matching analysis, the 3-year CSS and OS rates in the NS group compared to the SA group were 80.3% versus 62.1% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.016) and 75.8% versus 55.5% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.006), the 3-year CSS and OS rates in the NS group compared to the ST group were 71.3% versus 68.3% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.560) and 69.8% versus 62.9% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.330), the 3-year CSS and OS rates in the SA group compared to the ST group were 54.6% versus 66.7% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.220) and 50.2% versus 57.9% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.290), respectively. The predictive nomogram for OS in T1b-2N0-1 patients ultimately incorporated five clinicopathological variables: T stage, N stage, age, examined lymph nodes, and therapy modality. The nomogram C-index for predicting OS was 0.648, 0.663, and 0.666 in the training group, external validation group-1, and external validation group-2, respectively. The 1-year, 3-year, and 5-year predicted AUC values of the OS prediction model were 0.659, 0.639, and 0.612 for the training group, and 0.786, 0.758, and 0.692 for validation group-1, and 0.805, 0.760, and 0.693 for validation group-2, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For patients with stage T1b-2N0-1 esophageal cancer, neoadjuvant therapy significantly improves prognosis compared to surgery alone, those presenting with positive lymph nodes after upfront surgery can achieve survival benefits from adjuvant therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000001886","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:01:21Z","timestamp":1719392481000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of long-term survival of neoadjuvant therapy plus surgery versus upfront surgery and the role of adjuvant therapy for T1b-2N0-1 esophageal cancer: a population study of the SEER database and Chinese cohort"],"prefix":"10.1097","volume":"111","author":[{"given":"Lingling","family":"Xia","sequence":"first","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Cai","sequence":"additional","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkai","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Qiu","sequence":"additional","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshun","family":"Chen","sequence":"additional","affiliation":[{"name":"Cancer Center, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20260304","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of esophageal squamous cell carcinoma","volume":"154","author":"Abnet","year":"2018","journal-title":"Gastroenterology"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1440-1746.2009.05824.x","article-title":"Epidemiology of esophageal cancer: orient to Occident. Effects of chronology, geography and ethnicity","volume":"24","author":"Hongo","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS Trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.athoracsur.2011.10.061","article-title":"Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2N0 esophageal cancer patients due to inaccurate preoperative staging","volume":"93","author":"Zhang","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1245\/s10434-014-3929-6","article-title":"Treatment of clinical T2N0M0 esophageal cancer","volume":"21","author":"Hardacker","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejso.2018.02.005","article-title":"Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: a population-based cohort study","volume":"44","author":"Markar Sheraz","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1245\/s10434-023-14441-z","article-title":"The effect of neoadjuvant therapy on esophagectomy for cT2N0M0 esophageal adenocarcinoma","volume":"31","author":"Rodriguez-Quintero","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"Pt A","key":"R11-20260304","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijsu.2018.04.053","article-title":"Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options","volume":"54","author":"Mota","year":"2018","journal-title":"Int J Surg"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J Clin Oncol"},{"key":"R14-20260304","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.athoracsur.2011.04.004","article-title":"Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease","volume":"92","author":"Stiles","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jtcvs.2018.01.006","article-title":"Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: a decision analysis","volume":"155","author":"Semenkovich","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R16-20260304","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/bjs.10121","article-title":"Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer","volume":"103","author":"Bekkar","year":"2016","journal-title":"Br J Surg"},{"key":"R17-20260304","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R18-20260304","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/cas.13606","article-title":"Endoscopy screening effect on stage distributions of esophageal cancer: a cluster randomized cohort study in China","volume":"109","author":"Guan","year":"2018","journal-title":"Cancer Sci"},{"key":"R19-20260304","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/a-1593-4401","article-title":"Predictive value of preoperative endoscopic ultrasound (EUS) after neoadjuvant chemotherapy in locally advanced esophagogastric cancer - data from a randomized German phase II trial","volume":"43","author":"Sivanathan","year":"2022","journal-title":"Ultraschall Med"},{"key":"R20-20260304","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1572-0241.2005.41167.x","article-title":"Endoscopic ultrasound errors in esophageal cancer","volume":"100","author":"Zuccaro","year":"2005","journal-title":"Am J Gasteroenterol"},{"key":"R21-20260304","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jtcvs.2006.09.023","article-title":"T2N0M0 esophageal cancer","volume":"133","author":"Rice","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jss.2023.10.006","article-title":"Defining pathologic upstaging in cT1b esophageal cancer: should we consider neoadjuvant therapy?","volume":"295","author":"Mann","year":"2023","journal-title":"J Surg Res"},{"key":"R23-20260304","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.athoracsur.2019.04.008","article-title":"Neoadjuvant therapy vs upfront surgery for clinical T2N0 esophageal cancer: a systematic review","volume":"108","author":"Kidane","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R24-20260304","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.athoracsur.2013.03.093","article-title":"Evaluation of the reliability of clinical staging of T2N0 esophageal cancer: a review of the society of thoracic surgeons database","volume":"96","author":"Crabtree","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/JTO.0000000000000228","article-title":"Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer","volume":"9","author":"Speicher","year":"2014","journal-title":"J Thorac Oncol"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s11605-022-05441-7","article-title":"Management of clinical T2N0 esophageal and gastroesophageal junction adenocarcinoma: what is the optimal treatment?","volume":"26","author":"Perez Holguin","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"R27-20260304","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.athoracsur.2020.05.089","article-title":"Patterns of use of induction therapy for T2N0 esophageal cancer","volume":"111","author":"Rhodin","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R28-20260304","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijsu.2020.06.046","article-title":"A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma","volume":"80","author":"Lin","year":"2020","journal-title":"Int J Surg"},{"key":"R29-20260304","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/SLA.0000000000004958","article-title":"Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data","volume":"277","author":"Yang","year":"2023","journal-title":"Ann Surg"},{"key":"R30-20260304","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2019.06.020","article-title":"A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy","volume":"140","author":"Yu","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:06:40Z","timestamp":1772626000000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000001886","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"2024-05-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}